2008•HaematologicaOpen access
Treatment of light chain deposition disease with bortezomib and dexamethasone
Efstathios Kastritis, Magdalini Migkou, Maria Gavriatopoulou, P. Zirogiannis, Valsamakis Hadjikonstantinou, Meletios Α. Dimopoulos
Open full text 77 citations
Abstract
Light chain deposition disease (LCDD) is a rare plasma cell dyscrasia characterized by deposition of immunoglobulin fragments. The kidneys are almost always affected while heart, liver and other tissues are occasionally involved. About 50% of patients with LCDD have concurrent myeloma, however most
Open-access reader